Medicines Australia makes submission to the 2015-2016 federal budget

12 February 2015
australia-big

Trade body Medicines Australia has made a submission to the 2015-2016 Federal Budget, asking the Australian government to recognize the ongoing sustainability of the Pharmaceutical Benefits Scheme (PBS) resulting from reforms introduced in collaboration with industry.

The industry body also seeks a commitment to grow investment opportunities for innovation and research in pharma.

Tim James, chief executive of Medicines Australia, said: “The Australian pharmaceutical industry contributes meaningfully to the health and wealth of the nation, however it requires a stable and predictable policy environment to encourage investment, grow and prosper. We call on government to affirm a commitment to work with industry to maintain a sustainable PBS; recognise the need for predictability for industry; and to provide certainty by ensuring no new unilateral PBS saving measures are introduced in the 2015-16 Budget. A decade of PBS reforms are generating billions of dollars in savings and providing headroom to list new products on the PBS.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical